Dennis McGonagle

29.7k total citations · 8 hit papers
362 papers, 18.7k citations indexed

About

Dennis McGonagle is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Dennis McGonagle has authored 362 papers receiving a total of 18.7k indexed citations (citations by other indexed papers that have themselves been cited), including 224 papers in Rheumatology, 134 papers in Immunology and 91 papers in Hematology. Recurrent topics in Dennis McGonagle's work include Spondyloarthritis Studies and Treatments (142 papers), Psoriasis: Treatment and Pathogenesis (100 papers) and Autoimmune and Inflammatory Disorders Research (83 papers). Dennis McGonagle is often cited by papers focused on Spondyloarthritis Studies and Treatments (142 papers), Psoriasis: Treatment and Pathogenesis (100 papers) and Autoimmune and Inflammatory Disorders Research (83 papers). Dennis McGonagle collaborates with scholars based in United Kingdom, Italy and Israel. Dennis McGonagle's co-authors include Elena Jones, Paul Emery, Charlie Bridgewood, Peter V. Giannoudis, Κassem Sharif, Michael Benjamin, Rozalia Dimitriou, Michael McDermott, Anthony O’Regan and Helena Marzo‐Ortega and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Medicine.

In The Last Decade

Dennis McGonagle

341 papers receiving 18.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bone regeneration: current concepts and future directions

2011 1.5k citations Elena Jones, Dennis McGonagle et al. profile →
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease

2020 1.2k citations Dennis McGonagle, Κassem Sharif et al. profile →
Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies

2007 929 citations Elena Jones, Dennis McGonagle et al. profile →
A Proposed Classification of the Immunological Diseases

2006 557 citations Dennis McGonagle et al. profile →
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia

2020 543 citations Dennis McGonagle, Κassem Sharif et al. profile →
Enthesitis: from pathophysiology to treatment

2017 326 citations Georg Schett, Rik Lories et al. profile →
The Global, Regional, and National Burden of Psoriasis: Results and Insights From the Global Burden of Disease 2019 Study

2021 203 citations Giovanni Damiani, Nicola Luigi Bragazzi et al. profile →
Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis

2020 180 citations Dennis McGonagle et al. profile →

Peers

Countries citing papers authored by Dennis McGonagle

Since Specialization

Citations

This map shows the geographic impact of Dennis McGonagle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis McGonagle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis McGonagle more than expected).

Fields of papers citing papers by Dennis McGonagle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis McGonagle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis McGonagle. The network helps show where Dennis McGonagle may publish in the future.

Co-authorship network of co-authors of Dennis McGonagle

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis McGonagle. A scholar is included among the top collaborators of Dennis McGonagle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis McGonagle. Dennis McGonagle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial 2025 ·Nature Medicine ·Iain B. McInnes, Laura C. Coates, Philip J. Mease, (unknown), Arthur Kavanaugh, Lihi Eder, Georg Schett, Alan Kivitz, Dennis McGonagle, (unknown), A. Godwood, (unknown), Kristian Reich, Christopher T. Ritchlin, Joseph F. Merola	1
2	Late‐Onset Spondyloarthritis Presenting as Glucocorticoid‐Resistant Polymyalgia Rheumatica: A Hitherto Underappreciated Entity in Which Tumor Necrosis Factor or Interleukin ‐17 Blockade May Have a Therapeutic Role 2025 ·Arthritis & Rheumatology ·(unknown), Gabriele De Marco, (unknown), Katya Meridor, Tom Macleod, Andrew Scarsbrook, Kulveer Mankia, Edward M Vital, Andrew Barr, Colin Pease, Helena Marzo‐Ortega, Sarah Mackie, Dennis McGonagle	0
3	Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis 2024 ·Clinical Rheumatology ·Proton Rahman, Iain B. McInnes, Atul Deodhar, Georg Schett, Phillip J. Mease, M. Shawi, J. Daniel, Jonathan Sherlock, Alexa P. Kollmeier, Xie L. Xu, Shihong Sheng, Christopher T. Ritchlin, Dennis McGonagle	0
4	The Association Between Sarcoidosis and Malignancy: A Comprehensive Population-Based Cohort Study 2024 ·Journal of Clinical Medicine ·(unknown), (unknown), Κassem Sharif, (unknown), (unknown), (unknown), Arnon D. Cohen, ‬‬‬‬Abdulla Watad, Dennis McGonagle, Howard Amital, Paula David	2
5	Risk factors for psoriatic arthritis development in psoriasis patients: myths, pitfalls, and pearls 2024 ·Clinical and Experimental Rheumatology ·(unknown), ‬‬‬‬Abdulla Watad, Ivan Giovannini, (unknown), Enzo Errichetti, Paula David, Gabriele De Marco, Dennis McGonagle, Alen Zabotti	4
6	Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis 2024 ·Lara D. Veeken ·Dennis McGonagle, Arthur Kavanaugh, Iain B. McInnes, Lars Erik Kristensen, Joseph F. Merola, Bruce Strober, Rebecca Bolce, Jeffrey Lisse, (unknown), Christophe Sapin, Christopher T. Ritchlin	2
7	Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage 2024 ·RMD Open ·Alen Zabotti, Filippo Fagni, Laure Gossec, Ivan Giovannini, Michael Sticherling, Annarita Tullio, Xenofon Baraliakos, Gabriele De Marco, Salvatore De Vita, Enzo Errichetti, Luca Quartuccio, Ettore Silvagni, Josef S Smolen, Ilaria Tinazzi, ‬‬‬‬Abdulla Watad, Georg Schett, Dennis McGonagle, David Simón	16
8	Hidradenitis suppurativa associated telomere‐methylome dysregulations in blood 2023 ·Journal of the European Academy of Dermatology and Venereology ·Uppala Radhakrishna, (unknown), Devendrasinh Jhala, (unknown), (unknown), (unknown), Maulikkumar Patel, (unknown), (unknown), Rakesh Rawal, Santo Raffaele Mercuri, Dennis McGonagle, Gregor B. E. Jemec, Giovanni Damiani	8
9	Anti-IL-5 biologics and rheumatoid arthritis: a single-centre 500 patient year exposure analysis 2023 ·RMD Open ·(unknown), I. Clifton, (unknown), Charlie Bridgewood, (unknown), Tom Macleod, Dennis McGonagle	4
10	Guselkumab, a Selective Interleukin‐23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies 2023 ·ACR Open Rheumatology ·Dennis McGonagle, Iain B. McInnes, Atul Deodhar, Georg Schett, M. Shawi, Soumya D. Chakravarty, Alexa P. Kollmeier, Xie L. Xu, Shihong Sheng, Stephen Xu, Christopher T. Ritchlin, Proton Rahman, Phillip J. Mease	4
11	Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 2022 ·SHILAP Revista de lepidopterología ·Paolo Gisondi, Francesco Bellinato, Martina Maurelli, (unknown), Alen Zabotti, Dennis McGonagle, Giampiero Girolomoni	19
12	Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider 2021 ·Annals of the Rheumatic Diseases ·Alessia Alunno, Aurélie Najm, Xavier Mariette, Gabriele De Marco, (unknown), (unknown), Dennis McGonagle, Pedro Machado	26
13	Chest pain mimicking pulmonary embolism may be a common presentation of COVID‐19 in ambulant patients without other typical features of infection 2021 ·Journal of Internal Medicine ·Stephanie R Harrison, (unknown), Charlie Bridgewood, Andrew Scarsbrook, Helena Marzo‐Ortega, Dennis McGonagle	6
14	BSR Spondyloarthritis Course, 27 February 2020. Spondyloarthritis: pathogenesis, diagnosis and management 2020 ·Rheumatology Advances in Practice ·Helena Marzo‐Ortega, Ai Lyn Tan, Dennis McGonagle, David Pickles, (unknown), (unknown), Laura C. Coates, Stefan Siebert, Philip Helliwell	1
15	Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia 2019 ·RMD Open ·Alen Zabotti, Dennis McGonagle, Ivan Giovannini, Enzo Errichetti, Francesca Zuliani, Anna Zanetti, Ilaria Tinazzi, Orazio De Lucia, Alberto Batticciotto, Luca Idolazzi, Garifallia Sakellariou, Sara Zandonella Callegher, Stefania Sacco, Luca Quartuccio, Annamaria Iagnocco, Salvatore De Vita	72
16	The Impact of Intermittent Fasting (Ramadan Fasting) on Psoriatic Arthritis Disease Activity, Enthesitis, and Dactylitis: A Multicentre Study 2019 ·Nutrients ·Mohammad Adawi, Giovanni Damiani, Nicola Luigi Bragazzi, Charlie Bridgewood, Alessia Pacifico, Rosalynn R.Z. Conic, Aldo Morrone, Piergiorgio Malagoli, Paolo D. Pigatto, Howard Amital, Dennis McGonagle, ‬‬‬‬Abdulla Watad	70
17	Spondyloarthritis: new insights into clinical aspects, translational immunology and therapeutics 2018 ·Current Opinion in Rheumatology ·Charlie Bridgewood, ‬‬‬‬Abdulla Watad, Richard Cuthbert, Dennis McGonagle	22
18	The burden of depression in systemic sclerosis patients: a nationwide population-based study 2018 ·Journal of Affective Disorders ·Nicola Luigi Bragazzi, ‬‬‬‬Abdulla Watad, (unknown), Dennis McGonagle, Hussein Mahagna, Doron Comaneshter, Howard Amital, Arnon D. Cohen, Daniela Amital	23
19	New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice 2017 ·Therapeutic Advances in Chronic Disease ·(unknown), Dennis McGonagle, Helena Marzo‐Ortega	35
20	Tofacitinib inhibits inflammation and new bone formation in murine spondyloarthritis but does not adversely inhibit normal human MSC function 2015 ·Ghent University Academic Bibliography (Ghent University) ·Rik Lories, (unknown), Richard Cuthbert, Elena Jones, (unknown), Dennis McGonagle, Dirk Elewaut	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact